| Application no. and date | 15196358.4 (espacenet) (Federated) (European Patent Register), 20110809 | | Patent/reg. no. and date | DK/EP 3042917, 20180221 | | Publication date | 20160713 | | Priority no. and date | US 373026 P, 20100812 | | EP pub. no. and date |
EP 3042917 20160713 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | P81600348DK01E | | Inventor | Demattos, Ronald, c/o Eli Lilly & Company
Lilly Corporate Centre
Indianapolis, Indiana 46285, US,
Lu, Jirong, c/o Eli Lilly & Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US,
Tang, Ying, c/o Eli Lilly & Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 25/28 (2006.01) , C07K 16/18 (2006.01) , G01N 33/577 (2006.01) | | Title | ANTI-N3PGLU-AMYLOID-BETA-PEPTID-ANTISTOFFER OG ANVENDELSER DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
